Product Name | MF | CAS | Details |
---|
Hepatitis C Virus NS5 Genotype 1a protein | Details |
Uridine 5'-triphosphate | C9H15N2O15P3 | 63-39-8 | Details |
5'-O-Tosylthymidine | C17H20N2O7S | 7253-19-2 | Details |
D-Idose, Aqueous solution | C6H12O6 | 5978-95-0 | Details |
2-Methyl-3-furoic acid | C6H6O3 | 6947-94-0 | Details |
(-)-Beta-peltatin-5-o-beta-D-glucopyranoside | C28H32O13 | 11024-59-2 | Details |
Ethyl 1-bromocyclohexane-1-carboxylate | C9H15BrO2 | 41949-98-8 | Details |
2-Fluoro-6-methylbenzylamine | C8H10FN | 1146290-54-1 | Details |
C.I.Reactive Red 120 | C44H30Cl2N14O20S6 | 61951-82-4 | Details |
1-(Ethylamino)propan-2-one hydrochloride | C5H12ClNO | 1314969-78-2 | Details |
(S)-(+)-3-Methyl-1-pentanol | C6H14O | 42072-39-9 | Details |
1-(2-Methylfuran-3-carbonyl)piperazine hydrochloride | C10H15ClN2O2 | 1193388-14-5 | Details |
2-(N,N-Dipropylsulfamoyl)benzoic acid | C13H19NO4S | 1016723-74-2 | Details |
2-(1-Aminoethyl)-5-methyl-1,3-thiazole-4-carboxylic acid hydrochloride | C7H11ClN2O2S | 2138413-45-1 | Details |
N-(2-Piperidin-4-ylethyl)methanesulfonamide hydrochloride | C8H19ClN2O2S | 70922-37-1 | Details |
2-(5-Formyl-1H-pyrrol-2-yl)acetic acid | C7H7NO3 | 345971-25-7 | Details |
Zatebradine | C26H36N2O5 | 85175-67-3 | Details |
MLF1IP protein (His tag) | Details |
N2-Acetyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-guanosine 3'-CE phosphoramidite | C48H64N7O9PSi | 944138-03-8 | Details |
9α,13α-Epidioxyabiet-8(14)-en-18-oic acid | C20H30O4 | 116499-73-1 | Details |
2-[(3-Bromophenyl)formamido]-3-hydroxypropanoic acid | C10H10BrNO4 | 1396999-37-3 | Details |
Dr 4485 hydrochloride | C26H29Cl3N2O | 402942-53-4 | Details |
1-(2,4-Difluorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid | C10H6F2N2O3 | 1152604-44-8 | Details |
6b,7b,15b,16b-Dimethylene-3b,5b-dihydroxyandrostan-17-one | C21H30O3 | 82543-16-6 | Details |
4-Nitroaniline Hydrochloride | C6H7ClN2O2 | 15873-51-5 | Details |
RXRA Blocking Peptide | Details |
3',4',5,7-Tetramethoxyflavone | C19H18O6 | 855-97-0 | Details |
Cyclododecanol | C12H24O | 1724-39-6 | Details |
2,6-Dibromobenzaldehyde | C7H4Br2O | 67713-23-9 | Details |
PF 4778574 | C19H22N2O3S2 | 1219633-99-4 | Details |
(R)-2-(1,2,3,4-Tetrahydroisoquinolin-3-yl)acetic acid hydrochloride | C11H12ClNO2 | 332064-61-6 | Details |
3-Bromo-5-ethoxy-4-methoxybenzonitrile | C10H10BrNO2 | 515831-52-4 | Details |
3-(3,3-Dimethylazetidin-2-yl)pyridine | C10H14N2 | 1781447-52-6 | Details |
1-[(tert-butoxy)carbonyl]-5,5-difluoropiperidine-2-carboxylic acid | C11H17F2NO4 | 1255663-95-6 | Details |
Nephrin antibody | Details |
4-[(2-Bromo-4-fluorophenyl)methyl]oxan-4-amine hydrochloride | C12H16BrClFNO | 1803609-61-1 | Details |
5-Chloro-3-(oxan-4-yl)-1,2,4-thiadiazole | C7H9ClN2OS | 1423042-51-6 | Details |
[3-(Trifluoromethyl)pyridin-4-yl]methanamine dihydrochloride | C7H8ClF3N2 | 1798725-24-2 | Details |
BIZ 114 | C24H40O3 | 2099120-74-6 | Details |
Dehydroequol | C15H12O3 | 81267-65-4 | Details |
bromo(methanesulfonyl)methane | C2H5BrO2S | 78967-61-0 | Details |
2-(Azepan-2-yl)-1-phenylethan-1-one hydrochloride | C14H20ClNO | 1376225-40-9 | Details |
H-EW-OH | Details |
Delphinidin-3-o-arabinoside chloride | C20H19ClO11 | 171370-55-1 | Details |
2-((4-chlorophenyl)sulfonyl)-3-(5-nitro-2-(4-(trifluoromethyl)phenoxy)phenyl)prop-2-enenitrile | C22H12ClF3N2O5S | 1025258-96-1 | Details |
(1R,4R,5S)-4-tert-Butyldimethylsiloxymethyl-5-tert-butyldimethylsilyloxycyclohex-2en-1-ol | C19H40O3Si2 | Details |
1-(3-Amino-2-methylphenyl)-3,3-dimethylurea | C10H15N3O | 1525599-45-4 | Details |
β-MSH, monkey | C98H138N28O29S | 17750-75-3 | Details |
3-Phenylamino-propionic acid | C9H11NO2 | 5652-38-0 | Details |
3-Methyl-1-[(pyrrolidin-2-yl)methyl]urea hydrochloride | C7H16ClN3O | 2044834-44-6 | Details |
3-(Trifluoromethyl)pyridine-2-carboximidamide dihydrochloride | 1989672-37-8 | Details |
Aldol??518 alpha-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 | C29H29ClN2O7 | 2484873-05-2 | Details |
MAP3K1 antibody (HRP) | Details |
1-(4-Bromo-3-fluorophenyl)ethan-1-ol | C8H8BrFO | 1394783-32-4 | Details |
Phenyl Bromoacetate | C8H7BrO2 | 620-72-4 | Details |
Diptoindonesin G | C21H12O6 | 1190948-58-3 | Details |
Adenosine 5'-monophosphate | C10H14N5O7P | 61-19-8 | Details |
Sarsapogenin | C27H44O3 | 126-19-2 | Details |
2,2-Difluorobutane-1-sulfonyl chloride | C4H7ClF2O2S | 1780685-02-0 | Details |
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-isoindole-1,3-dione | C14H16BNO4 | 1220423-08-4 | Details |
3,5-Diiodoaniline hydrochloride | C6H6ClI2N | 1803607-49-9 | Details |
H-IGEVDVEQHTLAK^-OH | Details |
CAPNS2 Blocking Peptide | Details |
2-[(Carbamothioylmethyl)(methyl)amino]-N-(2,4,6-trimethylphenyl)acetamide | C14H21N3OS | 871548-22-0 | Details |
1-(2-Chloro-5-fluoropyrimidin-4-yl)pyrrolidin-3-amine | C8H10ClFN4 | 1310558-47-4 | Details |
N-[2-(1-Methyl-1H-1,3-benzodiazol-2-yl)-1-phenylethylidene]hydroxylamine | C16H15N3O | 929974-07-2 | Details |
HHIP antibody | Details |
N-(2-(Methylsulfonyl)phenyl)formamide | C8H9NO3S | 93493-76-6 | Details |
1-Benzoyl-2-methylpiperidine-2-carboxylic acid | C14H17NO3 | 162648-37-5 | Details |
SH3BGRL Blocking Peptide | Details |
5-Amino-2,4-dimethoxybenzoic acid hydrochloride | C9H12ClNO4 | 878749-52-1 | Details |
1-(2-Chloroethyl)-4-methyl-2,6,7-trioxabicyclo[2.2.2]octane | C8H13ClO3 | 84786-96-9 | Details |
1-[2-(Propan-2-yloxy)ethyl]cyclopropan-1-amine hydrochloride | C8H17NO.ClH | 1864016-48-7 | Details |
(2S)-2-Amino-4-phenylbutan-1-ol hydrochloride | C10H16ClNO | 150935-38-9 | Details |
1,2-Dilauroyl-sn-glycero-3-phosphoethanolamine | C29H58NO8P | 59752-57-7 | Details |
4-methyl-5-phenyl-4H-1,2,4-triazole-3-carboxylate lithium (I) | C10H10LiN3O2 | 1803582-61-7 | Details |
RANK antibody (PE) | Details |
3-Isopropyl-4,5-dihydroisoxazole-5-carboxylic acid | C7H11NO3 | 1177346-52-9 | Details |
tert-Butyl 6-(aminomethyl)-2-azabicyclo[4.1.0]heptane-2-carboxylate | C12H22N2O2 | 1504412-80-9 | Details |
alpha SNAP antibody | Details |
5-Amino-4-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic acid | C13H13N3O6 | 1198299-72-7 | Details |
N-(4-Methylbenzyl)propan-1-amine | C11H17N | 39190-96-0 | Details |
1,4-dibromo-2-(difluoromethoxy)benzene | C7H4Br2F2O | 1000575-26-7 | Details |
Goat anti Human IgG (Fc) (Agarose Conjugated) | Details |
4-(3,4-Dichlorophenyl)-1,3-oxazol-2-amine | C9H6Cl2N2O | 1250201-47-8 | Details |
Proteinase 3 protein | Details |
2-Chloro-N-[4-(2-oxopyrrolidin-1-yl)phenyl]propanamide | C13H15ClN2O2 | 1098347-65-9 | Details |
2-(3-Amino-1H-pyrazol-1-yl)-N-methylacetamide | C6H10N4O | 1183109-57-0 | Details |
2-(Aminomethyl)-2-methylbutanedioic acid hydrochloride | C6H12ClNO4 | 86970-16-3 | Details |
H-HETTFNSI-OH | Details |
2-[({1-[(tert-Butoxy)carbonyl]-1-azaspiro[5.5]undecan-4-yl}({[(9H-fluoren-9-yl)methoxy]carbonyl})amino)methyl]furan-3-carboxylic aci d | C36H42N2O7 | 2138040-04-5 | Details |
Amidepsine A | C29H29NO11 | 169181-28-6 | Details |
H-Tyr-Arg-Gly-Asp-Ser-OH trifluoroacetate salt | C24H36N8O10 | 134282-68-1 | Details |
PDGF Receptor beta antibody (Tyr751) | Details |
6-Hydroxy dexamethasone | C22H29FO6 | 55879-47-5 | Details |
FAM19A3 antibody | Details |
Sulfadimidine-BSA | Details |
Exopolysaccharide - from Bacillus polymixa | Details |
GIPC1 Blocking Peptide | Details |
1-(2-Methoxypyridin-3-yl)ethanone | C8H9NO2 | 131674-40-3 | Details |
Product Total: Product Page: | ||||
826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 |